pdf

Law360: Meet the Top Attys in AbbVie’s Antitrust Battle Royal

June 07, 2019

A judge in the US District Court for the Northern District of Illinois consolidated numerous proposed class action suits against pharmaceutical companies’ patents and "pay-for-delay" deals. The action follows allegations that AbbVie attempted to “protect the market” for Humira by creating a “patent thicket” and working closely with biosimilar producers.

“BigLaw brawlers” from O’Melveny, including partners Ben Bradshaw and Ian Simmons and counsel Stephen McIntyre, are representing Samsung Bioepis in the antitrust matter.